Express Scripts reports on 2016 drug spending by health plan clients

AHA News Now

Drug spending per member for public health insurance exchange plans sponsored by Express Scripts clients increased 14% in 2016, driven by increases in both unit costs and use, according to a new report by the pharmacy benefit management company. Drug spending per member for Medicaid, Medicare Part D, and... read more

Topic: Access and Coverage
Tag: drug prices

AHA brief examines how hospitals are holding the line on costs

AHA News Now

Hospitals and health systems have been leaders in controlling costs in the health care sector, with hospital price growth in 2015 at the slowest annual rate since 1998 and Medicare spending growth for hospital services at its lowest level in 17 years, according to a data brief on hospital care costs... read more

Topic: Advocacy and Public Policy
Tags: Electronic Health Records, Coverage, regulation, workforce, chronic conditions, drug prices

CMS: Part D drug rebates/price concessions raise beneficiary costs, subsidies

AHA News Now

Manufacturer rebates and other price concessions reported by Medicare Part D prescription drug plans after the point-of-sale grew about 22% annually between 2010 and 2015, contributing to higher beneficiary cost-sharing and Medicare subsidy payments, according to a report released last week by the Centers... read more

Topic: Advocacy and Public Policy
Tag: drug prices

OIG: High-price drugs driving up cost of Medicare Part D catastrophic coverage

AHA News Now

Federal payments for Part D catastrophic coverage exceeded $33 billion in 2015, more than triple the amount paid in 2010, according to a new report by the Department of Health and Human Services’ Office of Inspector General. Drugs with an average price of more than $1,000 per month accounted for almost... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

HRSA issues final rule on 340B drug ceiling prices, manufacturer penalties

AHA News Now

The Health Resources and Services Administration today released a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program. Required by the Affordable Care Act, the rule amends Section 340B of the Public Health Service Act to impose monetary... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

HHS report to Congress shows increase in prescription drug spending

AHA News Now

Growth in prescription drug spending has accelerated considerably in recent years, and it is projected to continue rising during the next decade, according to a report the Department of Health and Human Services recently submitted to Congress. Specifically, the report shows that growth in retail... read more

Topic: Advocacy and Public Policy
Tag: drug prices

CMS: National health spending grows 5.8% in 2015

AHA News Now

U.S. spending on health care grew 5.8% in 2015, primarily due to increased use and intensity of services as millions gained health coverage, as well as continued significant growth in spending for retail prescription drugs, the Centers for Medicare & Medicaid Services reported today in Health Affairs.... read more

Topic: Advocacy and Public Policy
Tags: physicians, Medicare, Coverage, Medicaid, drug prices

CMS releases 2015 data on Medicare, Medicaid drug spending

AHA News Now

Forty drugs accounted for 69% of Medicare spending for drugs administered in physician and hospital outpatient settings last year, according to an updated dashboard released today by the Centers for Medicare & Medicaid Services. Six of the drugs accounted for more than $1 billion each in Part B spending,... read more

Topic: Advocacy and Public Policy
Tags: Medicare, Medicaid, drug prices

State leaders propose solutions to rising prescription drug costs

AHA News Now

The National Academy for State Health Policy today issued 11 proposals to help states rein in rising prescription drug costs. Developed by a panel of state leaders, the policy options include: increasing price transparency; creating a public utility model to oversee drug prices; bulk purchasing critical... read more

Topic: Advocacy and Public Policy
Tag: drug prices

High Drug Prices Hurt Everyone

Blog

More evidence this week of how unchecked drug price increases are forcing hospitals to make tough choices and are a serious economic threat to the patients and communities we serve. An AHA/Federation of American Hospitals-commissioned report by the University of Chicago’s NORC showed inpatient hospital... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Keyword Search

Date